Ardelyx (ARDX) Other financing activities (2014 - 2026)
Ardelyx (ARDX) posted Other financing activities of $5.4 million for Q1 2026, up 202.99% on a QoQ basis from -$5.3 million in Q4 2025, and up 267.21% year-over-year from $1.5 million in Q1 2025.
Ardelyx (ARDX) Other financing activities (2014 - 2026) Analysis & Trends
Ardelyx's Other financing activities history runs 13 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- Quarterly Other financing activities rose 267.21% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 327.72% YoY) and the FY2023 annual result came in at $5.0 million, up 2375.25% from the prior year.
- Other financing activities was $5.4 million for Q1 2026 at Ardelyx, up from -$5.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $9.5 million in Q3 2022 and bottomed at -$9.4 million in Q4 2022.
- A 5-year average of $665250.0 and a median of $1.2 million in 2025 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 1510.5% in 2024, while the deepest fall reached 290.97% in 2024.
- Ardelyx's Other financing activities stood at -$9.4 million in 2022, then jumped by 142.02% to $3.9 million in 2023, then tumbled by 290.97% to -$7.5 million in 2024, then increased by 29.79% to -$5.3 million in 2025, then jumped by 202.99% to $5.4 million in 2026.
- Business Quant data shows ARDX's Other financing activities at $5.4 million in Q1 2026, -$5.3 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | -5.28 Mn |
| Dec 31, 2025 | -5.28 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 988,000.00 |
| Jun 30, 2025 | 988,000.00 |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |